Gonzàlez-Medina A.

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure

Article

Abstract: Background-Clinical trials in heart failure have focused on the improvement in symptoms or decreases

Palabras claves:

Angiotensin, Heart Failure, Neprilysin, Receptors

Autores:

Andersen K., Arango J.L., Arnold J.M., Belohlávek J., Böhm M., Boytsov S., Burgess L.J., Cabrera W., Calvo C., Chen C.H., Desai A.S., Dukat A., Erglis A., Fu M., Gomez E., Gong J., Gonzàlez-Medina A., Hagège A.A., Huang J., Katova T., Kiatchoosakun S., Kim K.S., Kozan Ö., Lefkowitz M.P., Llamas E.B., Martinez F., McMurray J.J.V., Mendoza I., Merkely B., Mosterd A., Negrusz-Kawecka M., Packer M., Peuhkurinen K., Ramires F.J.A., Refsgaard J., Rizkala A.R., Rosenthal A., Rouleau J.L., Senni M., Shi V.C., Sibulo A.S., Silva-Cardoso J., Solomon S.D., Squire I.B., Starling R.C., Swedberg K., Teerlink J.R., Vanhaecke J., Vinereanu D., Wong R.C.C., Yan Duarte, Zile M.

Fuentes:

scopus